Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reuter

Showing results (481-490 of 581) with videos related to

Pageof 59
Sort By:
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
The Journal of Pathology|May 7, 2011
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinomaHikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, et al.
Human Pathology|February 15, 2001
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologistsW C Allsbrook, K A Mangold, M H Johnson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2021
EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinomaKhaleel I Al-Obaidy, Julia A Bridge, Liang Cheng, et al.
Journal of the National Cancer Institute|November 29, 2013
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinomaA Ari Hakimi, Helena Furberg, Emily C Zabor, et al.
European Urology|October 6, 2012
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinomaA Ari Hakimi, Ying-Bei Chen, James Wren, et al.
Urology|July 30, 2020
RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell TumorsDouglas A Mata, Soo-Ryum Yang, Donna C Ferguson, et al.
Human Pathology|April 5, 2019
A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcomaSounak Gupta, Carlos P Sosa, Farhad Kosari, et al.
Cancer Research|January 28, 2010
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formationMartin K Thomsen, Laurence Ambroisine, Sarah Wynn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtypeA Ari Hakimi, Satish K Tickoo, Anders Jacobsen, et al.
Pageof 59

Showing results (481-490 of 581) with videos related to

Sort By:
Pageof 59
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
The Journal of Pathology|May 7, 2011
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinomaHikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, et al.
Human Pathology|February 15, 2001
Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologistsW C Allsbrook, K A Mangold, M H Johnson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2021
EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinomaKhaleel I Al-Obaidy, Julia A Bridge, Liang Cheng, et al.
Journal of the National Cancer Institute|November 29, 2013
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinomaA Ari Hakimi, Helena Furberg, Emily C Zabor, et al.
European Urology|October 6, 2012
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinomaA Ari Hakimi, Ying-Bei Chen, James Wren, et al.
Urology|July 30, 2020
RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell TumorsDouglas A Mata, Soo-Ryum Yang, Donna C Ferguson, et al.
Human Pathology|April 5, 2019
A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcomaSounak Gupta, Carlos P Sosa, Farhad Kosari, et al.
Cancer Research|January 28, 2010
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formationMartin K Thomsen, Laurence Ambroisine, Sarah Wynn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtypeA Ari Hakimi, Satish K Tickoo, Anders Jacobsen, et al.
Pageof 59